Organogenesis Holdings Inc (ORGO) — Cash Flow-to-Debt Ratio
Organogenesis Holdings Inc (ORGO) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of $3.08 Million could theoretically repay 0% of its total liabilities ($123.85 Million) in one year. See how much free cash does Organogenesis Holdings Inc generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Organogenesis Holdings Inc Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Organogenesis Holdings Inc across 11 annual periods. Also explore net asset momentum of Organogenesis Holdings Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Organogenesis Holdings Inc (2001–2024)
Year-by-year debt coverage analysis for Organogenesis Holdings Inc. For market capitalisation and broader financial context, see Organogenesis Holdings Inc (ORGO) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | $14.21 Million | $112.57 Million | ▼ -26.0% |
| 2023 | 0.17x | $30.92 Million | $181.36 Million | ▲ +26.0% |
| 2022 | 0.14x | $24.86 Million | $183.69 Million | ▼ -55.9% |
| 2021 | 0.31x | $61.98 Million | $201.92 Million | ▲ +733.4% |
| 2020 | 0.04x | $5.47 Million | $148.41 Million | ▲ +118.1% |
| 2019 | -0.20x | $-33.53 Million | $165.10 Million | ▲ +61.0% |
| 2018 | -0.52x | $-60.74 Million | $116.64 Million | ▼ -1212.0% |
| 2017 | -0.04x | $-586.60K | $14.78 Million | ▲ +20.0% |
| 2016 | -0.05x | $-562.23K | $11.33 Million | ▲ +99.8% |
| 2015 | -24.48x | $-10.19 Million | $416.43K | ▼ -8145.9% |
| 2001 | -0.30x | $-1.40 Million | $4.70 Million | — |